$Unitedhealth(UNH.US)

The market is currently obsessed with short-term margin compression and regulatory noise. However, the fundamental role of UNH in the US healthcare system remains indispensable.

I am holding through the drawdown. With a solid 3.2% dividend yield, I am getting paid to wait for the business to reset.

Not selling at these depressed valuations. I view this as a test of conviction. If management can stabilize medical costs (MCR) in the coming quarters, the rebound could be significant.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.